NFKB2 and Meckel syndrome, type 1: For example, the expression of BMAL1, NFκB2 and IL6 in patients with MES 3 was higher compared to patients with moderate or mild disease, and the expression levels of PPARγ and PGC1α were lower in patients with MES 3 compared to patients with moderate or mild disease (Figure 2B).